Speakers: 

• Susan Wood RD - Matthew's Friends Clinics, UK 
• Neil Bindeman PhD - Exec. Dir. Primary Care and Community Neurology Society

Sue Wood discusses why there is so much scientific interest into the possibility of managing brain tumours with KDT.

Topics covered include:

• Overview of current clinical evidence
• Barriers to accessing KDT on NHS
• The patient experience